Adel Sammain

Dr. Adel Sammain

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
NKNicolas Kluger
Nicolas Kluger
CTC. Taieb
C. Taieb
JBJ. Bedran
J. Bedran
LPL. Payraud
L. Payraud
CBC. Beausillon
C. Beausillon
CCC. Comte
C. Comte

8 February 2024 in JEADV Clinical Practice
Verified
Journal Article
Open access
BSBarbara Schuster
Barbara Schuster
Adel SammainAdel Sammain
Adel Sammain
Skin of colour, defined as Fitzpatrick skin types IV–VI, is especially susceptible to hyperpigmentation concerns such as melasma and postinflammatory hyperpigmentation (PIH). Treating hyperpigmentation in skin of colour is challenging due to increased risk of PIH, which can be induced by the treatments. Isobutylamido‐Thiazolyl‐Resorcinol (ITR), a tyrosinase inhibitor, has previously been identified as an effective and safe solution for hyperpigmentation, inhibiting melanin production without common side effects. This review evaluates available evidence on ITR's efficacy and safety for the management of hyperpigmentation in skin types IV–VI. Three publications reporting four studies were reviewed. Two randomised controlled trials assessed the efficacy and tolerability of ITR for the management of melasma in patients with skin of colour, whereas one randomised clinical trial and one observational real‐world study explored therapeutic benefits for patients with acne‐related PIH. A total of 234 participants completed the four reviewed studies, of which 232 were skin of colour. In a randomised vehicle‐controlled trial, ITR significantly improved Melasma Area and Severity Index scores and quality of life over 24 weeks of application compared to baseline and vehicle. A comparative clinical trial showed ITR, alone or with hyaluronic acid, effectively reduced melasma. A randomised vehicle‐controlled study in patients with acne‐related PIH showed ITR significantly reduced PIH visibility as compared to baseline and vehicle. An observational real‐world study confirmed effective PIH reduction by ITR in a real‐life setting. All studies showed good tolerability of the examined ITR‐containing formulations. The results collectively support ITR as a safe and effective cosmetic solution in skin of colour. ITR emerges as a reliable hyperpigmentation management option for this patients groups, backed by robust methodologies. Future research should include more patients with Fitzpatrick skin type VI and explore potential benefits of combining ITR and laser treatments in skin of colour to reduce PIH risk.

24 May 2024 in JEADV Clinical Practice
Verified
Journal Article
Open access
AMAldo Morrone
Aldo Morrone
EAElva Abril
Elva Abril
ICIlaria Cavallo
Ilaria Cavallo
FSFrancesca Sivori
Francesca Sivori
ISIsabella Sperduti
Isabella Sperduti
FPFulvia Pimpinelli
Fulvia Pimpinelli
Background: Patients with human immunodeficiency virus (HIV) infection may present a large variety of skin manifestations, often associated with significant morbidity. In turn, dermatological diseases may represent an early sign of HIV infection, particularly in resource‐limited settings.Objectives: This study aimed to assess the spectrum of dermatological diseases and their potential value as clinical proxies for the early detection and management of HIV in a rural region of Ethiopia.Methods: The study was performed on a population of 67,161 patients with skin diseases attending the Italian Dermatological Center in Mekele, Tigray region, Ethiopia. HIV infection was diagnosed in 1892 individuals (1065 female), all naïve to antiretroviral therapy.Results: Infectious skin diseases were present in 57.2% of the total HIV population. Among the infectious skin manifestations, dermatophytosis (20.5%), impetigo (5.9%), candidiasis (4.7%) and molluscum contagiosum (4.7%) were significantly more represented in patients with HIV infection (p < 0.001). Regarding the noninfectious manifestations, pruritus and atrophy of the papillae on the tongue were significantly associated with HIV (p < 0.001). Notably, females had a significantly higher incidence of dermatophytosis and seborrheic dermatitis as compared to their male counterparts (p < 0.001), whereas scabies, psoriasis and leishmaniasis were significantly more frequent in males (p < 0.001).Conclusions: Skin manifestations are common in HIV patients, often reflecting compromised immune status. In addition, Dermatophytosis and pruritus were the most frequently reported manifestations of HIV, thus representing useful clinical proxies to raise the suspicion of an underlying HIV infection. Besides, gender differences in skin manifestations should also be considered in the clinical evaluation.

27 May 2024 in JEADV Clinical Practice
Verified
Journal Article
Open access
Adel SammainAdel Sammain
Adel Sammain
MBMarco Borghi
Marco Borghi
AMAldo Morrone
Aldo Morrone
Background: Currently, European and especially Italian healthcare systems are being challenged with providing medical care to an increasing number of refugees but also to the homeless living on the streets, in reception facilities or cohabitation. In 2022, over 200,000 irregular arrivals of migrants to Europe were recorded, coming from mainly African and also Asian countries and frequently via Mediterranean migration routes.Objectives: This study aims to report the results of a social support programme to provide treatment and improve health‐related quality of life (HrQoL) in refugees and homeless people.Methods: Observational study during the year 2022, including patients with an immigration background visiting the Clinica dell'Istituto di S. Maria e S. Gallicano di Roma, Italy (IRCCS), or being homeless during this observational study.Results: We have seen 210 patients. In 177 cases (84.3%), a definitive diagnosis is known. Most frequent skin conditions were infectious, allergic or due to secondary inflammation. We also saw rare cutaneous conditions like Madelung disease or Darier disease.Conclusions: We provided dermatological consultation and treatment to this very vulnerable population, and our experience shows that this social support programme to enable access to dermatological consultation for the poor was able to improve not only the clinical condition but also the HrQoL 4 weeks after consultation and beginning of treatment.